Serum uric acid and acute coronary syndrome: Case-Control study
International Journal of Environmental and Biological Sciences · 10.04.2026 · 1 (1)
DOI: 10.63939/7evcfd57 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift International Journal of Environmental and Biological Sciences, online erschienen am 10.04.2026. Verfasst von Mohammed Mahmood Abed und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Acute Coronary Syndrome represents a challenge to the global public health, because of the high morbidity and mortality. Identifying the risk factors and biomarkers is important for early detection, risk stratification, and effective management. Recent studies suggest a potential association between elevated serum uric acid levels and Acute Coronary Syndrome, yet the relationship remains poorly understood and need further investigation.
Objective
This study aims to assess the relationship between serum uric acid levels and the incidence of ACS in a defined population. thereby assessing its potential as a biomarker for detection and prognosis.
Methods
Employing a case-control design, this study will involve participants diagnosed with ACS at IBN SINA Hospital and a matched control group of apparently healthy individuals. Exclusion criteria include chronic kidney disease, malignancies, active inflammatory conditions, and the use of drugs affecting serum uric acid levels. Data collection will focus on demographic information, medical history, clinical characteristics, and serum uric acid levels, determined through blood sample analysis.
Results
Our study involved 64 ACS cases with a mean age of 59.39±11.886 years and 60 healthy controls with a mean age of 56.35±8.631 years. We observed that the median serum uric acid level was significantly higher in ACS cases (341.0) compared to controls (333.0) with a p-value of 0.046, indicating a statistically significant difference. Gender-based analysis revealed a significant difference in serum uric acid levels among females between cases and controls (p=0.035), but not among males (p=0.602). Age group analysis showed a significant difference only in the 70-79 age group (p=0.045). The ROC analysis suggested that serum uric acid level has a modest discriminatory ability for ACS with an area under the curve of 0.604 (p=0.046).
Conclusion
Elevated serum uric acid levels are associated with an increased risk of ACS, particularly among females and in older age groups. Serum uric acid could serve as a potential biomarker for ACS detection and prognosis, though its utility may vary across different demographic groups. Our findings highlight the importance of considering serum uric acid levels in the risk stratification and management of ACS patients
Zitieren
APA
Abed, M. M., & Al-hamdany, D. A. (2026). Serum uric acid and acute coronary syndrome: Case-Control study. International Journal of Environmental and Biological Sciences, 1(1). https://doi.org/10.63939/7evcfd57
Vancouver
Abed MM, Al-hamdany DA. Serum uric acid and acute coronary syndrome: Case-Control study. International Journal of Environmental and Biological Sciences. 2026;1(1). doi:10.63939/7evcfd57
BibTeX
@article{Abed2026,
author = {Abed, Mohammed Mahmood and Al-hamdany, Dhiyaa Abdulkadir},
title = {Serum uric acid and acute coronary syndrome: Case-Control study},
journal = {International Journal of Environmental and Biological Sciences},
year = {2026},
volume = {1},
number = {1},
doi = {10.63939/7evcfd57}
}
EUVIMED